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Abstract: Presently, the overuse of antibiotics is a great problem all over the world. The reason for this phenomenon is both primary and 
secondary resistance. Primary resistance is a congenital feature of microbes and does not depend on its contact with a drug. It is chromo-
somally coded and cannot be transmitted to other species of bacteria. Secondary resistance, on the other hand, develops as a result of con-
tact with the antibiotic substance. Genes located in plasmids are responsible for the formation of this type of resistance. One plasmid often 
contains resistance genes for several different antibiotics. Plasmids can transfer gene-encoded resistance from one bacterial cell to another 
by conjugation and transduction. As a result of the overuse of antibiotics in humans and animals, a growing number of infections – such 
as pneumonia, salmonellosis, tuberculosis, and gonorrhea – are becoming more troublesome to treat. Antibiotic resistance leads also to 
longer hospital stays, higher medical costs and finally increased mortality. Now people are finally becoming aware of the consequences 
of the overuse of antibiotics. Thus, interest in natural bacteriostatic materials, such as plant essential oils, has observably grown. A num-
ber of scientific studies have confirmed the antimicrobial activity of plant-derived essential oils against pathogenic bacteria, including 
Pseudo monas aeruginosa. A very important advantage of plant oils is the fact that they are active in low, sub-lethal concentrations, without 
provoking the acquisition resistance mechanisms in bacteria. The aim of this review was to explain the mechanisms of antibiotic resistance 
formation on the example of Pseudomonas aeruginosa and to demonstrate that it is worth looking for alternative treatment methods which 
can lead to limiting the use of antibiotics. Finally, this work tries to explain how the oils work.
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PRZECIWDROBNOUSTROJOWA AKTYWNOŚĆ OLEJKÓW ETERYCZNYCH SZANSĄ ROZWIĄZANIA
PROBLEMU ANTYBIOTYKOODPORNOŚCI NA PRZYKŁADZIE BAKTERII PSEUDOMONAS SPP.
Streszczenie: Nadużywanie antybiotyków stanowi ogromny problem na całym świecie, powodując wzrost antybiotykoodporności u pato-
gennych bakterii. Powodem tego zjawiska jest zarówno oporność pierwotna, jak i wtórna. Oporność pierwotna jest cechą wrodzoną 
drobnoustrojów i nie zależy od jego kontaktu z lekiem. Kodowana jest chromosomalnie i nie może być przekazywana innym gatunkom 
bakterii. Oporność wtórna natomiast pojawia się w wyniku kontaktu z substancją antybiotykową. Za powstawanie tego typu oporności 
odpowiadają geny zlokalizowane w plazmidach. Jeden plazmid zawiera często geny oporności na kilka różnych antybiotyków. Plazmidy 
mogą przenosić geny kodujące oporność z jednej komórki bakteryjnej na inną na drodze koniugacji i transdukcji. W wyniku nadużywa-
nia antybiotyków u ludzi i zwierząt coraz większa liczba infekcji – takich jak zapalenie płuc, salmonelloza, gruźlica i rzeżączka – staje się 
coraz trudniejsza w leczeniu. Odporność na antybiotyki prowadzi również do dłuższych pobytów w szpitalu, wyższych kosztów leczenia 
i ostatecznie do zwiększenia śmiertelności. Obecnie ludzie zaczynają być wreszcie świadomi konsekwencji nadużywania silnych środków 
bakteriobójczych. Dlatego poszukuje się rozwiązań alternatywnych. Przykładem jest wykorzystanie bakteriostatycznej aktywności lej-
ków roślinnych pochodzenia roślinnego. Wiele badań naukowych potwierdziło działanie przeciwdrobnoustrojowe olejków eterycznych 
pochodzenia roślinnego wobec bakterii chorobotwórczych, w tym Pseudomonas aeruginosa. Bardzo ważną zaletą olejów roślinnych jest 
fakt, że są aktywne w niskich, sub-letalnych stężeniach, bez powodowania mechanizmów oporności u bakterii. Celem niniejszej pracy 
było wyjaśnienie mechanizmów powstawania oporności na antybiotyki na przykładzie bakterii Pseudomonas aeruginosa oraz wskazanie 
konieczności poszukiwania alternatywnych metod terapii, które mogłyby przynajmniej częściowo przyczynić się do ograniczenia spoży-
wania antybiotyków. Podjęto także próbę wyjaśnienia mechanizmów oddziaływania olejów na komórki bakterii. 
1.Wstęp. 2. Charakterystyka bakterii z rodzaju Pseudomonas. 2.1. Pseudomonas aeruginosa. 3. Mechanizmy antybiotykooporności 
u  Pseudo monas spp. 3.1. Oporność wewnętrzna 3.2. Oporność adaptacyjna. 3.3. Oporność plazmidowa. 4. Najczęstsza oporność kli-
nicznych szczepów P. aeruginosa na antybiotyki. 4.1. Oporność na aminoglikozydy. 4.2. Oporność na fluorochinolony. 4.3. Oporność na 
cefalosporyny. 5. Roślinne olejki eteryczne – alternatywa dla antybiotyków. 5.1. Przeciwdrobnoustrojowa aktywność olejków eterycznych 
względem Pseudomonas spp. 5.2. Mechanizm oddziaływania olejków eterycznych na komórki bakterii. 6. Podsumowanie 
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1. Introduction
The increase in consumption of antibiotics has pro-
voked the formation of resistance mechanisms in bacte-
ria as a result of chromosomal changes or the exchange 
of genetic material via plasmids and transposons. This 
problem involves many pathogenic bacteria, including 
Pseudomonas spp. For instance, P. aeruginosa (respon-
sible for severe nosocomial infections) is a  clinically 
significant pathogen with confirmed resistance to 
multiple classes of antibiotics, such as fluoroquinolo-
nes, β-lactam antibiotics, and aminoglycosides [9, 53, 
78, 81, 85]. The overuse of antibiotics in treatment and 
in industry will only further increase resistance, and 
will thus render it impossible to treat infections caused 
by drug resistant bacteria. Therefore, it is necessary 
to reduce the consumption of antibiotics and look for 
alternative substances with antimicrobial activity, which 
are not antibiotics, like essential oils from plants.
Essential oils (EOs) are in fact not oils, but they 
are very poorly soluble in water, and this makes them 
similar to oils. Plant-derived EOs can be obtained from 
various plant parts, including seeds, flower, buds, twigs, 
leaves, woods, fruits, and roots. They are usually pre-
pared by fragrance extraction techniques such as dis-
tillation (including steam distillation), cold pressing, 
or extraction (maceration) [24, 89, 92]. Generally, EOs 
are complex mixtures of hundreds of individual aroma 
compounds [2]. All of these bioactive components 
have their own significant activity and that is why EOs 
acquire antimicrobial [73], antioxidant [20], antimy-
cotic [13], antiviral [84], antiparasitic [94], antitoxico-
genic and insecticidal [2] properties. 
The majority of EOs are classified as GRAS (Gener-
ally Recognized As Safe). Moreover, due to their fra-
grance and flavour as well as antimicrobial properties, 
they can be used in food products [9–10, 48, 81, 88]. 
Although the food industry primarily uses EOs as fla-
vourings, they represent a rich source of natural anti-
microbials for foods preservation, which is currently 
being widely studied [4, 30, 32, 40]. The interest in EOs 
and their application in food preservation has been sig-
nificantly amplified in recent years by the increasingly 
negative consumer perception of synthetic preserva-
tives [40]. It has been demonstrated that EOs are able 
to inhibit the growth of some food spoilage bacteria 
such as Clostridium spp. (among others C. botulinum, 
C. perfringens) [46], Bacillus spp. (B. stearothermophilus, 
B. cereus) [29], Lactobacillus spp. (L. acidophilus) [65] 
and also food-related Pseudomonas spp. (P. fluorescens, 
P. aeruginosa, P. lundensis, P. fragi, P. putida, P. orientalis) 
[6, 49–50, 70–71].
Despite pioneering work that has elucidated the 
mode of antimicrobial action of a few EOs constituents 
in model food systems or in real food [among others 
4, 30, 32], any detailed knowledge about how most of 
the compounds work is still lacking [40]. This knowl-
edge is necessary to predict how EO`s work on different 
microorganisms cells.
The purpose of this review is to provide an over-
view of current knowledge about the mechanism of 
antibiotic resistance in bacteria on the example of the 
Pseudomonas species, antimicrobial activity as well as 
EOs mode of action and their constituents. 
2. The characteristics of Pseudomonas genus
The genus Pseudomonas was first described by 
Migula in 1894 in just two concise sentences: “Cells 
with polar organs of motility. Formation of spores 
occurs in some species, but it is rare” [61]. Additional 
information about Pseudomonas was provided by 
Migula only in his later works. In 1895, he presented the 
Pseudomonas pyocyanea species which was renamed 
P. aeruginosa [48, 60–61].
Bacteria from the Pseudomonas genera were eagerly 
researched due to their widespread occurrence in the 
natural environment and capacity to grow in very sim-
ple media [72]. As a result of the study, it was demon-
strated that Pseudomonas plays a key role in the process 
of mineralizing organic matter in nature. Moreover, 
Dooren de Jong’s (1926) research introduced the meth-
odology for the phenotypic characterization of strains, 
which has had a significant impact on taxonomic 
research on the genus for nearly 40 years [51].
The Pseudomonas genus represents a diverse group 
of bacteria, characterized by an enormous metabolic 
capacity which is manifested, inter alia, by the ability 
to adapt to diverse and challenging environments, the 
capability to synthetize a variety of low-molecular-
weight biopolymers (among others, polyhydroxyalka-
noates and gellan) [62, 86] and also by the ability to 
degrade recalcitrant compounds (among others, atra-
zine, chlorobiphenyl, m-toluate, polychlorinated biphe-
nyl, nitrobenzene, 1,4-dichlorobenzene, 1,2,4-trichlo-
robenzene, naphthalene) [7, 15, 17, 19, 35, 42, 63, 69, 
97]. Moreover, it is one of the most ecologically signifi-
cant groups of bacteria – members of that genus are 
even present in terrestrial and marine environments 
and also in association with animals and plants. Such 
a free spread of bacteria from this species in the natural 
environment certainly results from its genomic diver-
sity and genetic adaptability [42]. 
The cells of bacteria belonging to Pseudomonas gen-
era are rod-shaped (less than 1 μm in diameter and not 
more than 4–5 μm in length) (Fig. 1), Gram-negative, 
polarly flagellated (in some species lateral flagella may 
also be produced) and they do not produce spores. Fim-
briae pili can be observed in the cells of many species 
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and probably all species are able to perform cell-to-cell 
contact, phage adsorption, attachment to cell surface 
and twitching motility. Pseudomonas strains are abso-
lute aerobes. For many strains, nitrate can act as an elec-
tron acceptor under aerobic conditions [72]. 
The Pseudomonas genus includes many pathogenic 
species. However, of these P. aeruginosa is the most 
commonly associated with antibiotic resistance.
2.1. Pseudomonas aeruginosa 
P. aeruginosa, like most Gram-negative pathogens, 
shows an increasing resistance to the majority of stand-
ard antibiotics used. A particularly dangerous phenom-
enon is the accumulation of resistance after the expo-
sure of these bacteria to antibiotics and cross-resistance 
between them. This is responsible for multi-drug resist-
ance, inter alia, in P. aeruginosa. This situation is par-
ticularly worrying because it creates a state reminiscent 
of the pre-antibiotic era [8]. 
P. aeruginosa is a common cause of health care-
associated infections, including pneumonia and infec-
tions of the bloodstream, urinary tract, and surgical-
site infections. Generally, more than 6,000 (13%) of the 
51,000 health care-associated P. aeruginosa infections 
occurring in the United States each year are multi-drug 
resistant. Thus, infections caused by P. aeruginosa are 
responsible for 400 deaths per year [52]. In Europe, it 
is estimated that P. aeruginosa is responsible for 10% of 
all hospital-acquired infections, but this number is con-
stantly on the rise [3, 8, 80]. The factors influencing the 
growing resistance in P. aeruginosa include the low per-
meability of its cell wall, the genetic capacity to express 
a wide repertoire of resistance mechanisms, the consti-
tutive expression of various efflux pumps, and the pro-
duction of antibiotic-inactivating enzymes. Moreover, 
the evidence that it can acquire additional resistance 
genes from other organisms via plasmids, transposons 
and bacteriophages is presented [48–49, 59]. Because 
of this complex multidrug resistance, P. aeruginosa is 
used as a model organism in research on resistance 
or susceptibility to synthetic or natural antibacterials 
[3, 5, 36, 47–49, 54, 81].
3. The mechanism of antibiotic resistance
 in Pseudomonas spp.
Antibiotics are among the most effective drugs 
used for human therapy. However, the synthesis of 
large numbers of antibiotics over the past four decades 
has caused complacency about the threat of bacterial 
resistance. Antibiotics are extensively used not only in 
human treatment but also for animal farming and agri-
cultural purposes. Unfortunately, they may be released 
into the natural environment and pollute it. The most 
evident consequence of antibiotic release into the natu-
ral environments is the phenomenon of resistant bac-
teria [9, 58]. Antibiotic-resistant bacteria that are very 
difficult or even impossible to eradicate are becoming 
increasingly common and are posing a global health 
crisis [58], because the release of residues containing 
human microbiota into an environment containing 
bacteria with resistive elements significantly increases 
the possibility that human-linked bacteria may acquire 
novel resistance determinants (the contact of human 
microbiota with other types of microbiota in different 
ecosystems will increase the possibility of genetic vari-
ation and the possible emergence of novel mechanisms 
of resistance) [58].
Generally, the resistance of bacteria to antibiotics 
can be determined by genes encoded in the chromo-
some or/and some mobile elements such as plasmids, 
transposons and integrons. However, new resistance 
mechanisms are constantly being described, and new 
genes and vectors of transmission are identified on 
a regular basis [8, 28, 58]. Bacteria may be naturally 
resistant to some groups of antibiotics or they can 
acquire resistance due to different genetic events such 
as mutations or the transfer of genetic information 
through direct contact with cells [23, 58]. 
3.1. Intrinsic resistance
Microorganisms in every environment on earth are 
exposed to antimicrobials and therefore some species 
(such as P. aeruginosa, Acinetobacter baumannii, Steno-
trophomonas maltophilia) possess an intrinsically low 
susceptibility to antibiotics. Free-living opportunistic 
pathogens often have large genomes that allow the colo-
nization of diverse environments through metabolic 
versatility that helps to degrade and resist the toxi city 
Fig. 1. Pseudomonas orientalis.
The cells were coloured by crystal violet (1000x, Axiovert).
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of compounds present in these ecosystems. This can 
include large numbers of biodegradative enzymes which 
cooperate in the modification and utilization of anti-
biotics as a food resource. Additionally, efflux pumps 
– originally involved in signal trafficking or resistance 
to toxic compounds produced by plants or rhizosphere-
associated microbiota – can be also used for effluxing 
antibiotics [41, 57, 77].
P. aeruginosa has been classified within the group 
of six highly antibiotic-resistant bacteria that are the 
primary causative agents of nosocomial (hospital-
acquired) infections [66]. An understanding of how 
this intrinsic resistance works was not easy to come by 
and was tackled by Murray et al. [66]. Primarily, they 
assumed that this resistance is related to gene expres-
sion in the presence of nonlethal levels of an antimicro-
bial with the idea that genes which are differentially 
regulated by low levels of an antimicrobial will pro-
vide an immediate insight into factors important for 
intrinsic resistance. However, it turned out that most of 
the genes identified in these studies have proven not to 
be significant in terms of intrinsic resistance. Another 
idea of theirs was based on screening transposon 
mutant libraries for increased or decreased suscepti-
bility to sub-MIC antimicrobials These studies revealed 
novel resistance determinants, although it is necessary 
to continue them in order to test more antibiotics and 
confirm all the results obtained [66].
3.2. Adaptive immunity
The exposure of susceptible P. aeruginosa to an 
aminoglycoside results in rapid drug concentration-
dependent killing followed by a phase of bacterial 
refractoriness characterized by slow drug concentra-
tion-independent killing. This adaptive resistance, 
which is distinct from the post-antibiotic effect and 
which disappears when the organism is no longer incu-
bated with the aminoglycoside, has been observed in 
vitro, in animal models of infection, and in patients 
with cystic fibrosis. This adaptive resistance is certainly 
not a result of mutation events. Reduced intracellular 
accumulation of aminoglycosides (which is concomi-
tant to adaptive resistance) was first interpreted as the 
consequence of a lower drug uptake across the bacte-
rial envelopes. Supporting this assumption, pleiotropic 
changes in the protein profiles of the cytoplasmic mem-
brane were detected in drug-exposed bacteria. The 
membrane potential – the driving force for drug entry 
–  appears to be marginally diminished in adaptively 
resistant bacteria. This finding agrees well with the 
observation that surviving bacteria grow normally dur-
ing the post-exposure refractory phase [37]. According 
to Lambert [49], aminoglycosides are not able to cross 
the outer membrane via porin channels. They promote 
their own uptake by binding to the lipopolysaccharide 
on the outer face of the membrane. Aminoglycosides 
Fig. 2. Resistance arising as a result of spontaneous mutation in chromosomal DNA.
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destroys the permeability barrier of the outer mem-
brane and allows the antibiotics to penetrate through 
the wall to the cytoplasmic membrane. Aminoglyco-
sides are then actively transported into the cells, where 
they interfere with protein synthesis at the ribosomes. 
Lambert [49] stated that resistance to aminoglycosides 
in laboratory strains of P. aeruginosa can be observed 
due to the overexpression of an outer membrane pro-
tein, OprH, which protects the lipopolysaccharides 
from binding the antibiotics but he underlined that 
this form of resistance has not been encountered widely 
in clinical isolates. 
In clinical practice, colistin and polymyxin B are 
most commonly used to treat P. aeruginosa infections. 
Thus, an increase in the number of polymyxins-resistant 
clinical isolates is being reported. The polymyxins are 
antimicrobial cyclic oligopeptides that interact with the 
phospholipids of bacterial cell membranes and thereby 
lead to increased cell wall permeability and, as a result, 
the death of the bacteria. In P. aeruginosa, polymyxin 
resistance is strictly associated with covalent addition 
of 4-amino-L-arabinose to phosphate groups within the 
lipid A and core oligosaccharide moieties of lipopoly-
saccharides. Genes in the arnBCADTEFpmrE operon 
encode enzymes responsible for synthesis and transfer 
of L-Ara4N to lipid A. This amino-sugar modification 
interferes with charge interactions between phosphate 
groups within lipopolysaccharides and amino groups 
within the cyclic polymixin oligopeptide. In Gram-
negative bacteria (including P. aeruginosa) the PmrAB 
and PhoPQ two-component regulatory systems stimu-
late transcription of the arnBCADTEF-pmrE operon in 
response to antimicrobial peptide exposure or divalent 
cation depletion. The sensor kinase PmrB activates 
the transcriptional response regulator PmrA through 
a phosphotransfer relay. Activation of PmrA can also 
occur as a consequence of pmrB mutation, previously 
observed as a cause of polymixin resistance in a labora-
tory strain as well as in clinical isolates [64].
3.3. Plasmid resistance
Plasmid is most commonly a fragment of double-
stranded circular DNA present in bacterial cells, physi-
cally separated from chromosomal DNA, which can 
replicate independently of the chromosome and has the 
ability to move to other cells. Some of the genes carried 
by the plasmid have a beneficial role for the host cells. 
One such example is enabling the host cell to survive 
in an environment that would be lethal or restrictive 
for growth. Some of these genes encode traits for anti-
biotic resistance as well as resistance to heavy metals 
[23, 55]. These resistance plasmids can be transferred 
from cell to cell through the mechanisms of transfor-
mation, conjugation and transduction. Conjugation is 
a very rare phenomenon, probably because it involves 
strict requirements. The donor cell must contain a con-
jugative element (it can be transposon or plasmid), and 
donor as well as recipient cells must establish physical 
contact that is sufficiently stable to allow the transfer 
of DNA. Both cells must be metabolically active to 
allow DNA synthesis (Fig. 3). The transduction pro-
cess requires a metabolically active donor cell in which 
transducing phage particles are produced during viral 
reproduction. The recipient can be spatially and tem-
porarily separated from the donor, because the genetic 
Fig. 3. Transfer of plasmids containing resistance genes from cell to cell.
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information in the transducing particle can persist. 
In the transduction process the resistance gene can be 
transferred by phages because they are often resistant 
to many physical and chemical agents and can survive 
in the environment. The transformation process does 
not require a living donor cell, because the release of 
DNA during death and cell lysis is sufficient to pro-
vide free DNA. The persistence and dissemination of 
DNA in the environment determine how far in time 
and space the recipient cell can be separated from the 
donor. The recipient must be physiologically active 
to be able to adopt DNA. A close genetic relationship 
between donor and recipient cells is not necessary for 
the transfer of genes by transformation [14, 55, 93]. 
Studies of multiple antibiotic resistance determined 
by plasmids and transposons in Gram-negative bacteria 
(including Pseudomonas spp.) lead to the discovery of 
integrons. Integrons are genetic elements that repre-
sent an excision – an integration system involved in 
the capture, mobilization, and expression of gene cas-
settes conferring resistance to β-lactams, aminoglyco-
sides, chloramphenicol, trimethoprim, sulfonamides, 
spectino mycin, streptomycin, and other antibiotics. 
All known integrons possess three elements essential 
for capturing exogenous genes: the integrase (intI) 
gene, a primary recombination site (attI), and a strong 
promoter. Gene cassettes are captured with the use of 
attI which allows recombination between the attI of 
the integron and a 59-nt element (also known as attC 
site) of a cassette. Unlike other excision-integration sys-
tems, integrons have multiple tandem gene cassettes 
inserted in one attI site and intI adjacent to attI rather 
than located in a gene cassette [43].
4. The most common resistance of clinical
 P. aeruginosa strains to antibiotics
P. aeruginosa, nosocomial pathogen, among other ill-
nesses, are a cause of pneumonia, cystic fibrosis, menin-
gitis, abscess, soft tissue infections, urinary tract infec-
tions, catheter associated infections, corneal infections 
and conjunctival erythema [15]. P. aeruginosa strains 
possess a diversity of resistance mechanisms which may 
lead to multi-drug or even pan-drug resistance. Stand-
ard antibiotic regimes against P. aeruginosa (penicillin, 
cephalosporins, aminoglycosides, fluoroquinolones, and 
carbapenems) are becoming increasingly ineffective due 
to the rise in drug resistance [15, 21, 23].
The mechanism of antibiotic resistance in P. aerugi-
nosa is multi-factorial and includes the expression of 
multiple antibiotic modifying enzymes (e.g, amino-
glycoside modifying enzymes, β-lactamases includ-
ing extended-spectrum -lactamases and metallo-
lactamases), antibiotic efflux pumps (MexAB-OprM, 
MexEF-OprN, MexCD-OprJ, and MexXY-OprM) as 
well as the acquisition of chromosomally or plasmid 
encoded antibiotic resistance genes. Also chromo-
somal mutations caused by alterations in DNA gyrase 
and topoisomerase IV gene and lower membrane 
permeability in P. aeruginosa can contribute to anti-
biotic resistance [15].
4.1. Resistance to aminoglycosides
Aminoglycosides are commonly used in the treat-
ment of infections caused by P. aeruginosa such as 
tobramycin, gentamicin, amikacin [79]. The mecha-
Fig. 4. Phenotypic expression of antibiotic resistance. Based on Doughari et al. [20].
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nism of bacterial resistance to aminoglycoside antibio-
tics is very complicated and can run in three directions. 
In the first mode, the antibiotic can be subjected to 
enzymatic modification, the structure of the cellular 
receptor may change and the membrane permeabil-
ity and transport of the antibiotic into the interior of 
the cell are disturbed [80, 83]. The second mechanism 
of bacterial resistance to aminoglycosides (character- 
i zed especially for Gram-negative bacteria, including 
P. aeruginosa) is based on the disruption of the energy-
dependent antibiotic transport system to the cell recep-
tor (ribosome 30S subunit), as a result of which the 
antibiotic does not reach the target site of action [80]. 
The third mechanism is based on a chromosomal 
mutation and leads to a change in the S12 protein of 
the ribosome 30S subunit and the loss of antibiotic 
binding ability [23]. Bolard et al. [98] documented that 
resistance of clinical strains of P. aeruginosa to amino-
glycosides resulted from the production of trans ferable 
aminoglycoside-modifying enzymes, of 16S rRNA 
methylases, and mutational derepression of intrinsic 
multidrug efflux [98].
4.2. Resistance to fluoroquinolones
Fluoroquinolones have a broad range of antibacte-
rial activity which is useful in the treatment of differ-
ent diseases (e.g., urinary tract infections, gastrointes-
tinal infections, respiratory tract infections, sexually 
transmitted diseases, bone and joint infections, and 
infections of the skin and soft tissue) [80]. The fluo-
roquinolones resistance genes are located in bacterial 
chromosome and mutations are the main mechanism of 
this resistance. The resistance to these antibiotics is pre-
dominantly caused by mutations in DNA topoisomer-
ase II (gyrase) and topoisomerase IV enzymes [79]. 
These genes are responsible for the introduction and/
or removal of supercoils in and the catenation/decate- 
nation of DNA. Thus, they play an essential role in the 
replication, transcription, recombination, and repair 
of DNA. Gyrase is the preferred target of fluoroquino- 
lones in Gram-negative bacteria; therefore, the resist-
ance mutation first occurred in this enzyme. In some 
highly resistant isolates, additional mutations in topoi-
somerase IV can be observed. Both gyrase and topoi-
somerase are each comprised of two subunits, with 
fluoroquinolones resistance mutations occurring typi-
cally in the region assigned as “quinolone resistance 
determining region” (QRDR) of GyrA and/or ParC. 
Such mutations commonly occurred in fluoroquino-
lones-resistant P. aeruginosa [79].
An active efflux of the agents via antibiotic efflux 
pump is a typical phenomenon in P. aeruginosa where 
efflux-mediated resistance to quinolones (along with 
mutations in the genes of gyrase and topoisomerase) 
seems to predominate as a mechanism of resistance 
to these agents. The active efflux mechanism is due to 
the broad substrate specificity of the fluoroquinolones 
efflux systems, which are capable of accommodating 
a variety of clinically relevant antimicrobial agents in 
addition to them [80]. Four members of the Resist-
ance Nodulation Division family of multi-drug efflux 
systems, MexAB-OprM, MexCD-OprJ, MexEF-oprN, 
and MexXY-OprM are described to accommodate fluo-
roquinolones. Expression of mexAB-oprM, controlled 
directly or indirectly by three repressors MexR, NalD 
and NalC and mutations in mexR, nalC and nalD, have 
been observed in fluoroquinolone-resistant clinical 
P. aeruginosa isolates [79]. 
4.3. Resistance to cephalosporins
Besides fluorquinolones, β-lactam antibiotics are 
most frequently applied in the treatment of bacterial 
infections (e.g, bacterial meningitis, otitis media, sal-
monellosis). During the past 30 years, emergence and 
dissemination of β-lactam resistance in some patho-
genic strains such as P. aeruginosa has become a seri-
ous problem worldwide. Of particular concern is the 
increasing resistance to 3rd and 4th cephalosporins gene-
ration and carbapenems. Gram-negative bacteria pursue 
various molecular strategies for developing resistance to 
these antibiotics, most commonly the ability to hydro-
lytic cleavage of the β-lactam ring of cephalosporins by 
β-lactamases, antibiotic expulsion by chromosomally 
encoded efflux mechanisms and reduced drug uptake 
owing to the loss of outer membrane porin proteins 
[79]. In P. aeruginosa four molecular classes (A-D) of 
β-lactamases, including metal dependent (Zn2+ – equir-
ing, class B) and metal-independent (active site serine, 
classes A, C, and D) β-lactamases have been observed 
(79). P. aeruginosa typically carries chromosomal genes 
for two of the β-lactamases. It acts as a class C cepha-
losporinase (AmpC) and a class D oxacillinase (PoxB) 
[79]. AmpC is a well-known β-lactamase while PoxB 
activity was only detected in lab mutants lacking AmpC. 
AmpC is induced by a number of β-lactam antibiotics; 
therefore, it contributes to the internal resistance to the 
number of β-lactam antibiotics. However, AmpC can-
not be induced by monobactams, the anti-pseudomonal 
penicillin piperacillin and many of the newer cepha-
losporins such as cefotaxime, ceftriaxone, ceftazidime 
and then the resistance is dependent upon mutational 
derepression of ampC (in fact, mutational derepression 
of ampC is the most common mechanism of resistance 
to β-lactams in P. aeruginosa) [79].
The original β-lactamases were plasmid-encoded 
class  A enzymes with limited-spectrum of activity 
that could only hydrolyze penicillin and an older nar-
row-spectrum of cephalosporins. However, there are 
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reports in the literature about the presence of acquired 
β-lactamases in P. aeruginosa with an extended-spec-
trum of β-lactamase (ESBL) enzymes (classes A and D) 
capable of hydrolyzing a broader range of β-lactams, 
including a broad spectrum of cephalosporins, mono-
bactams and carbapenemases (classes A, B and D) that 
hydrolyze most β-lactams, including carbapenems 
(excluding aztreonam) [76, 79].
Because bacteria produce effective resistance mech-
anisms against antibiotics commonly available and 
in use, and in addition, this resistance can be passed 
between them, the focus should turn to a quest for 
alternative methods of inhibiting bacterial metabolic 
activity. If, however, in some cases chemical antibiotics 
could be replaced by natural substances, the phenom-
enon of antibiotic abuse could be overcome and the 
spread of the antibiotic resistance phenomenon may 
be stopped or at least slowed down. Plant oils are an 
example of such natural bacteriostatic substances. There 
are currently many in vitro studies on the mechanisms 
of their antimicrobial activity. 
5. Essential oils from plants as a natural alternative
 for antibiotics
Essential oils are mixtures of many aromatic com-
pounds. They include, among others, terpenes, terpe-
noids, phenols and tannins, which determine their bio-
logical functions, such as antimicrobial, antioxidant and 
anti-inflammatory activity. Natural oils are found in the 
cells of oil plants, namely, those containing more than 
0.01% oil [26]. EOs are obtained from plants by steam 
distillation, cold pressing or extraction with organic 
solvents, as well as by a combination of these methods 
[11–12]. They have antimicrobial activity against many 
pathogenic microorganisms, including food pathogens 
and microbes responsible for the spoilage of food prod-
ucts. It is believed that due to differences in the cell wall 
structures of Gram-positive and Gram-negative bac-
teria, EOs have a weaker effect against Gram-negative 
bacteria, but oils containing thymol and carvacrol, for 
example, show comparable activity in both cases. Some 
EOs have a comparable or stronger antimicrobial effect 
than chemotherapeutics and preservatives. In addition, 
even long-term use of oils does not induce the immuni-
zation of microorganisms, as is the case with synthetic 
substances [12].
5.1. Antibacterial activity of plant EOs against
 Pseudomonas spp.
Many plant EOs are known to inhibit the growth 
of Pseudomonas strains [e.g., 3, 27, 31, 48, 56, 67, 68, 
74, 75, 82, 87, 94, 96]. The antibacterial activity against 
some Pseudomonas species of oregano, rosmarinus, 
thymus [1], satureja [16, 74, 75] eucalyptus [74], basil, 
citrus, fennel, lemongrass [75] has been confirmed. 
Examples of the minimal inhibitory concentrations 
(MIC) of selected EOs with biostatic activity against 
bacteria from Pseudomonas genera are collected in 
Table I. A comparison of the value of MICs is impos-
sible, because the authors used different units and in 
most cases the data needed to re-calculate such values 
are missing. However, the MIC values are generally very 
low. That ability of EOs to inhibit bacteria grow in low 
concentrations is the main advantage of using them. 
According to literature data, the exposure of cells to 
such concentrations of natural antimicrobial agents 
neither kills bacteria nor stops their growth and thus 
does not cause selective pressure or the development of 
resistance mechanisms in bacteria cells [74]. 
5.2. How EOs work on the bacteria cell
The mechanism of antimicrobial activity of EOs is 
closely related to the type and amount of antimicro-
bial-active compounds in their composition. The active 
ingredients of EOs are a diverse group of organic com-
pounds with a low molecular weight [12, 34, 40, 45]. 
The composition of the essential oil of a given plant may 
vary depending on the part of the plant from which 
the oil was obtained (leaves, flowers, etc.), the location 
and conditions of cultivation, and methods of isolation 
[12, 33, 45]. Due to the variability of the composition 
of EOs, the mechanism of their action is still not fully 
understood [34, 40, 48]. 
Pseudomonas bacteria are particularly resistant to 
antibiotics and disinfectants because of the increased 
coherence of the cytoplasmic membrane, due to the 
higher content of lipoproteins [44, 95]. Ingredients of 
EOs are characterized by high lipophilicity, thanks to 
which they have the ability to penetrate the membrane 
and cell wall of microbial cells. These molecules, after 
penetrating the cell, disrupt its integrity [34, 45]. It 
should be noted that the components of EOs can elimi-
nate bacterial plasmid antibiotic resistance by inhibiting 
the replication of a given plasmid, thanks to which they 
can also exhibit antimicrobial activity against strains 
resistant to previously used substances [45]. Unfortu-
nately, several factors still limit the effectiveness of EOs 
on bacterial cells. It has been shown that the penetra-
tion of essential oil components into Gram-negative 
bacteria cells is a more complicated process than in the 
case of Gram-positive bacteria due to differences in the 
structure of their cell walls [10, 12, 34, 45]. Differences 
in cell structure between bacterial species and strains 
also determine the potency of the antimicrobial activ-
ity of a given essential oil. It has been proved that the 
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Achillea millefolium > 1000 μg/ml N/A 85
Anethium graveolens N/A > 0.8% v/v 36–37
Aniba rosaeodora > 2.0% v/v N/A 84
Apium graveolens  > 0.8% v/v 36–37; 84
Artemisia dracunculus N/A  36–37
Boswellia carterii > 2.0% v/v N/A 84
Cananga odorata
Cedrus atlantica
Chamæmelum nobile N/A > 0.8% v/v 36–37
Cinnamomum cassia  0.05% v/v 
Cinnamomum verum  0.1% v/v
Cistus ladaniferus pineniferum   
Citrus aurantifolia > 2.0% v/v N/A 84
Citrus aurantium  > 0.8% v/v 36–37; 84
Citrus bergamia    
Citrus limetta N/A  36–37; 84
Citrus limon > 2.0% v/v  36–37; 84
Citrus x paradisi  N/A 84
Citrus reticulata N/A > 0.8% v/v 37
Citrus reticulata var. madurensis > 2.0% v/v N/A 84
Citrus sinensis N/A > 0.8% v/v 36–37
Commiphora myrrha > 2.0% v/v N/A 84
Coriandrum sativum  0.8% v/v 36–37
Corydothymus capitatus N/A 0.025% v/v
Cuminum cyminum  > 0.8% v/v
Cucurbita pepo > 2.0% v/v N/A 84
Cupressus sempervirens  > 0.8% v/v 36–37; 84
Curcuma longa N/A  36–37
Cymbopogon citratus > 2.0% v/v 0.8% v/v 
Cymbopogon martinii  0.2% v/v 
Cymbopogon nardus  0.4% v/v 
Daucus carota  N/A 84
Eucalyptus dives N/A > 0.8% v/v 36–37
Eucalyptus polybractea > 2.0% v/v N/A 84
Eugenia caryophyllus N/A 0.1% v/v 36–37
Foeniculum vulgare > 2.0% v/v N/A 84
Gaultheria procumbens
Juniperus communis
Laurus nobilis N/A > 0.8% v/v 36–37
Lavandula angustifolia > 2.0% v/v N/A 84
Lavandula latifolia N/A > 0.8% v/v 36–37
Macadamia integrifolia > 2.0% v/v N/A 54
Matricaria chamomilla 10.0 μg/ml  54
Melaleuca alternifolia > 2.0% v/v 0.8% v/v 36–37; 84
Melaleuca cajuputi  > 0.8% v/v
Table I
Minimum inhibitory concentrations of EOs against Pseudomonas strains
Origin of EO
Strain
P. putidaP. aeruginosa Reference
MIC
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formation of exopolysaccharides occurring in Pseudo-
monas species causes their greater resistance to EOs 
than other Gram-negative bacteria [45]. 
The ingredients of EOs, due to their hydrophobicity, 
can affect the proportion of unsaturated fatty acids in 
the cell membrane and change their structure. The use 
of concentrations of oils lower than the MIC value in 
relation to bacteria can cause an increase in the amount 
of unsaturated fatty acids responsible for the fluidity of 
the cell membrane, which results in structural changes 
of the membrane [45]. Phenolic compounds contained 
in EOs also have a significant influence on their anti-
bacterial activity. Treatment with thymol, carvacrol 
and eugenol may increase the content of saturated 
fatty acids while lowering the unsaturated fatty acid 
content in the bacterial cell membrane. This results in 
an increased stiffness of the cell membrane and even-
tually its degradation. Essential oil components may 
also affect the activity of enzymes responsible for the 
synthesis of fatty acids included in the outer layer of 
the cell [10, 12, 22].
Active substances in EOs can affect proteins in bac-
terial cells and affect cell division. These compounds 
also affect the expression of genes. They can affect the 
regulation and synthesis of, for example, enzymes or 
chaperone proteins, inter alia related to the thermal 
stress of the cell. The action of essential oil components 
in relation to cellular proteins completely disturbs the 
functioning of the bacterial cell [10, 12, 40, 45].
The production of ATP in bacterial cells takes place in 
the cytosol by glycolysis. There is a correlation between 
intracellular and extracellular ATP concentration. The 
Mentha piperita 3.0 μg/ml N/A 54
Mentha x piperita > 2.0% v/v  84
Mentha spicata   
Myristica fragrans N/A > 0.8% v/v 36–37
Myrtus communis cineoliferum   
Ocimum basilicum > 2.0% v/v  36–37; 84
Origanum majorana  0.4% v/v 
Origanum vulgare  N/A 84
Pelargonium graveolens   
Pimpinella anisum   
Pimenta dioica N/A 0.1% v/v 36–37
Pimenta racemosa > 2.0% v/v N/A 84
Pinus sylvestris  > 0.8% v/v 36–37; 84
Piper nigrum  N/A 84
Plantago major > 1000 μg/ml  85
Pogostemon patchouli > 2.0% v/v  84
Psidium guajava > 1000 μg/ml  85
Punica granatum
Rosmarinus officinalis > 2.0% v/v > 0.8% v/v 36–37; 84
Salvia lavandulifolia N/A 0.8% v/v 36–37
Salvia officinalis > 2.0% v/v N/A 84
Salvia sclarea
Santalum album
Satureja hortensis N/A 0.05% v/v 36–37
Syzygium aromaticum > 2.0% v/v N/A 84
Tea tree 4.0% v/v  87
Thymus vulgaris > 2.0% v/v 0.05% v/v 36–37; 84
Vetiveria zizanioides  N/A 84
Zingiber officinale  > 0.8% v/v 36–37; 84
Table I
Continued
Origin of EO
Strain
P. putidaP. aeruginosa Reference
MIC
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ingredients of EOs cause permeabilization of the cell 
membrane, thereby reducing the concentration of ATP 
inside the cell. Permeabilization of the cell membrane 
and leakage of ions (e.g. hydrogen and potassium) also 
causes excessive loss of inorganic phosphate, resulting 
in a reduction in the amount of intracellular ATP. The 
ATP content in the bacterial cell may also decrease due 
to the inhibitory activity of the oil components towards 
ATP-ase [10, 18, 40, 45, 48, 70]. EOs can affect bacterial 
cell metabolites [10, 40, 92, 95]. This effect may take 
place by interacting with metabolites already present in 
the cell or by altering metabolic pathways. This results 
in changes in the function of certain metabolites, as well 
as the synthesis of excessively small or large amounts 
of specific compounds. Changes in metabolic pathways 
may also result in the formation of new metabolites. This 
causes the occurrence of cellular stress and significant 
disturbances in the functioning of the cell [45].
EO components have the ability to modify the 
morphology of a bacterial cell. It has been shown that 
oblong-shaped cells are more sensitive to these com-
pounds than coccoid ones. Changes in bacterial mor-
phology are also different for Gram-positive and for 
Gram-negative bacteria. The action of EOs on bacteria 
can cause changes in the shape of cells, for example 
by extending or rounding them. It can be observed 
that bacterial cells treated with oils cease to be visibly 
separated from each other due to the degradation of 
their cell membranes. Damage to the protein-lipid 
membrane can lead to coagulation of the cytoplasm 
and a complete release of the cellular content. Changes 
of this type involve bacterial cell lysis [10].
The compounds included in the EOs are able to 
inhibit the phenomenon of Quorum Sensing (QS), 
which is an intercellular communication system occur-
ring at a sufficiently high cell density. QS regulates 
a  number of activities, such as biofilm formation, 
sporulation or virulence factors [19]. The expression 
of genes involved in QS results in the production of 
signalling molecules. The inhibition of the phenom-
enon by the components of oils takes place by inhibit-
ing the synthesis, transport or secretion of signalling 
molecules. This leads to a reduction in the formation of 
bacterial biofilms, proteolytic activity and to the reduc-
tion of bacterial virulence [48].
EOs have multidirectional antibacterial activity, 
which is associated with the diversity of their com-
position. Each of the biologically active compounds 
present in the essential oil has a different mechanism 
of action. There is a synergy between the compounds, 
which makes the oils work more comprehensively 
than all their components separately. In general, the 
activity of each essential oil consists of a series of 
activities of individual substances or their complexes, 
which results, inter alia, in decreasing cellular respira-
tion and lowering intracellular pH, and eventually may 
lead to the inhibition of bacterial cell growth or lysis 
[10, 12, 40, 45].
Although there are many scientific reports docu-
menting (in vitro) the strong antibacterial activity of 
essential oils against Gram-negative and Gram-positive 
bacteria, there are no reports from in vivo experiments. 
We can only find the information that some plant oils/
extracts are used in the folk medicine in Brazil to treat 
some bacterial infections [38]. Unfortunately, there is 
no data available on its form of application and we do 
not know the concentration of oils contained in natural 
medicines and how effective they are. 
Fig. 5. The mode of antibacterial action of essential oils.
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6. Summary
Bacterial adaptation to antibiotics through the 
last decades has been very successful, resulting in an 
increase in antibiotic resistance and posing consider-
able medical problems. Further overuse of antibiot-
ics will lead to serious consequences – the number 
of antibiotic resistant strains of different species will 
increase [25]. At present, throughout the world in gen-
eral (including Poland) Enterobacteriaceae producing 
the New Delhi-Metallo-beta-laktam-1 gene (NDM-1) 
(including Klebsiella pneumoniae strains assigned as 
New Delphi) is spreading at an alarming rate. NDM 
belongs to the group of metal-B-lactamases (MBL), 
which Pseudomonas aeruginosa can produce, after 
acquiring a gene conditioning them. Now, there is an 
increase in the number of isolated clinical strains that 
are currently producing MBL in the world. Those bac-
teria are resistant to all β-lactam antibiotics (apart from 
monobactams). They are a problem not only because 
of the limited possibilities to treat infections caused by 
them, but also due to the fact that they can convey the 
“super resistance gene” to other bacteria, often harm-
less, also transforming them into superbugs resistant 
to many commonly used drugs. The only way to pre-
vent the growing problem of antibiotic resistance is to 
rationalize the consumption of antibiotics and use them 
for industrial purposes. Therefore, the task for mod-
ern scientists is to find substances with bacteriostatic 
and bactericidal activity (with novel targets and modes 
of action), against which bacteria have not developed 
defence mechanisms. One such trend is the use of 
essential oils as inhibitors of bacterial growth.
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